Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 1/20 | 0.46 |
| ▸ | SSTR2 | P30874 | 13/20 | 0.43 |
| ▸ | SSTR4 | P31391 | 13/20 | 0.43 |
| ▸ | SSTR5 | P35346 | 12/20 | 0.43 |
| ▸ | SSTR3 | P32745 | 11/20 | 0.43 |
| ▸ | SSTR1 | P30872 | 8/20 | 0.43 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.39 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.39 |
| ▸ | ITGAV | P06756 | 1/20 | 0.39 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.39 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.39 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.39 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.39 |
| ▸ | KDM4A | O75164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24347569 | 0.83 | CXCR4 (0.49) | CXCR4SSTR2SSTR4SSTR5SSTR3 | |
| SCHEMBL24348580 | 0.83 | CXCR4 (0.49) | CXCR4SSTR2SSTR4SSTR5SSTR3 | |
| SCHEMBL24348095 | 0.82 | CXCR4 (0.52) | CXCR4SSTR2SSTR4SSTR5SSTR3 | |
| SCHEMBL24348770 | 0.75 | SSTR2 (0.44) | CXCR4SSTR2SSTR4SSTR5SSTR3 | |
| SCHEMBL22183395 | 0.75 | SSTR2 (0.59) | SSTR2SSTR4SSTR5SSTR3SSTR1 | |
| SCHEMBL22183468 | 0.74 | SSTR2 (0.59) | SSTR2SSTR4SSTR5SSTR3SSTR1 | |
| SCHEMBL17404637 | 0.69 | SSTR4 (0.66) | SSTR2SSTR4SSTR5SSTR3SSTR1 | |
| SCHEMBL18712360 | 0.69 | SSTR4 (0.65) | SSTR2SSTR4SSTR5SSTR3SSTR1 | |
| SCHEMBL19543860 | 0.69 | SSTR4 (0.62) | SSTR2SSTR4SSTR5SSTR3SSTR1 | |
| SCHEMBL16409450 | 0.68 | ITGB3 (0.51) | CXCR4ITGB3ITGB1ITGAVITGA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11160871-B2 | SSTR-targeted conjugates and particles and formulations thereof | TARVEDA THERAPEUTICS, INC. (US) | 2021-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11160871-B2 | SSTR-targeted conjugates and particles and formulations thereof | SSTR1, SSTR4, SSTR3 | CXCR4 1283/4885SSTR2 5/4885SSTR4 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.